Here we show that in MDA-MB-231 triple negative breast cancer cells basal levels of PTEN are enhanced by TMEPAI knockdown, which further increased by TGF-β treatment (Fig. 5A). This evidence concerns the gene TGFB1 and triple-negative breast carcinoma.